Abstract This questionnaire survey was conducted at 11 hospitals in Japan to determine vaccination coverage against seasonal influenza and the prevalence rate of influenza among pregnant Japanese women. Of 2,808 postpartum women who gave birth at the 11 hospitals during the study period from March 1, 2014, to July 31, 2014, 1,713 (61 %) participated in this study and 876 (51 %) reported having received vaccination against influenza in or after October 2013. Women aged <25 years had a significantly lower vaccination rate than those aged≥25 years (31 % vs. 53 %, respectively; p=0.0000). Eighty-seven (5.1 %) and 1,626 (94.9 %) women did and did not contract influenza, respectively. Although prior birth did not affect overall vaccination coverage (50 % for primiparous vs. 53 % for multiparous), multiparous women had a significantly higher rate of contracting influenza than primiparous women, irrespective of vaccination status (5.6 % vs. 2.2 % [p=0.0216] and 9.7 % vs. 3.5 % [p=0.0003] for women with and without vaccination, respectively). The 2013-2014 vaccination program significantly reduced the influenza infection rate by 35 % (3.9 % vs. 6.3 % for women with and without vaccination, respectively; p = 0.0272). Seventy-two (83 %) of the 87 women took antiviral agents for the treatment of influenza and two (2.3 %) required hospitalization. These results suggested that pregnant Japanese women had a high level of concern regarding seasonal influenza. However, campaigns targeting young pregnant Japanese
women, as well as multiparous women, for vaccination are needed in order to further reduce the incidence of influenza among pregnant Japanese women.
Introduction
Pregnant women are at an increased risk of severe influenzarelated complications [1] [2] [3] [4] [5] [6] [7] [8] [9] . Evidence from several countries demonstrated increased hospitalization rates and disproportionately higher rates of mortality in pregnant women during the previous seasonal influenza and pandemic (H1N1) 2009 [1] [2] [3] [4] [5] [6] [7] [8] [9] . However, there were no mortalities among pregnant women during the pandemic (H1N1) 2009 in Japan [10, 11] . At that time of pandemic (H1N1) 2009, pregnant Japanese women had a high level of concern regarding pandemic influenza because the Japan Society of Obstetrics and Gynecology (JSOG) aggressively intensified outreach to pregnant women, policy-makers, and medical workers, including medical doctors, midwives, and nurses, to minimize the number of cases of infection among pregnant women [10, 12] . Indeed, more than 60 % of candidates were vaccinated within 1.5 months after the availability of vaccine against the pandemic (H1N1) 2009 virus and half of all women infected with influenza had taken prophylactic antiviral drugs after coming into close contact with an infected person in Hokkaido, the northernmost and second largest island of Japan [13] .
However, to our knowledge, there have been no studies investigating how many pregnant Japanese women are vaccinated against seasonal influenza and how many pregnant Japanese women contracted seasonal influenza before or after the pandemic (H1N1) 2009. It may be important to determine the baseline level of concern regarding influenza among pregnant Japanese women in order to prepare for future avian influenza epidemics. Therefore, we conducted this multicenter study to determine vaccination coverage against seasonal influenza and the prevalence rate of influenza infection among pregnant Japanese women during the 2013-2014 influenza season.
Materials and methods
This multicenter observational study was conducted with the approval of the Institutional Review Boards of Hokkaido University Hospital and the following 11 hospitals widely dispersed throughout Japan that participated in this study: Nagasaki University Hospital, Rakuwakai Otowa Hospital, Toyama University Hospital, Mie Chuo Medical Center, Nippon Medical School Tama-Nagayama Hospital, National Center for Child Health and Development, University of Tsukuba Hospital, Jichi Medical University Hospital, Hakodate Central General Hospital, Sapporo Toho Hospital, and Hokkaido University Hospital.
In Japan, women usually remain at obstetric facilities for 4 to 8 days after giving birth. We conducted an anonymous questionnaire study (Table 1 ) among all postpartum women who gave birth at and after gestational week 22 and within 5 days after delivery before leaving the obstetric facility during the study period from March 1, 2014, to July 31, 2014. Therefore, the majority of these postpartum women conceived in or before October 2013.
All data are presented as means±standard deviation (SD). For the statistical analysis of categorical data, χ 2 or Fisher's exact test was applied. The statistical software package StatView 5.0 for Macintosh (SAS Institute, Inc. Cary, NC) was used for the data analysis. In all analyses, p<0.05 was taken to indicate statistical significance.
Results
During the 5-month study period, 2,808 women gave birth on and after gestational week 22 at the 11 participating hospitals. Preterm birth (at<37 weeks of gestation) occurred in 373 (13 %) women. A total of 1,713 (61 %) of the 2,808 women participated in this study (Table 2) . Although the response rate and vaccination coverage differed considerably between hospitals, the mean (SD) response rate was 62 % (22 %), and the mean vaccination rate was 53 % (13 %) for the 11 Maternal age affected vaccination coverage: women aged 24 years or less received vaccination significantly less often than those in the other age categories (Table 3 ). However, experience of prior birth did not affect the overall vaccination coverage (50 % for primiparous vs. 53 % for multiparous women), although a significantly larger number of primiparous women aged 25-29 years received the vaccination compared to multiparous women in the same age group (57 % vs. 44 %, respectively). In contrast, among women 35 years old or more, multiparous women tended to have a greater vaccination rate than primiparous women.
Eighty-seven (5.1 %) and 1,626 (94.9 %) women did and did not contract influenza, respectively ( Table 4 ). The prevalence of influenza did not differ markedly between hospitals, ranging from 3.4 % (10/298) in Jichi Medical University Hospital to 8.9 % (10/112) in Nagasaki University Hospital (mean±SD, 5.5 %±1.8 %). In the 1,626 women without influenza compared to the 87 women with influenza, the fraction sizes of women with vaccination and that of primiparous women were significantly greater ( Table 4 ). As this suggested that the experience of childbirth was a risk factor for contracting influenza, we analyzed the differences in the prevalence rates of influenza between primiparous and multiparous women according to maternal age (Fig. 1) . The infection rate was consistently higher for multiparous than Table 4 ). The effects of vaccination on the prevention of influenza were analyzed (Table 5) . Two women (one was vaccinated and the other was unvaccinated) contracted both influenza A and B viruses. The number of women infected with influenza A virus did not differ significantly between the 876 and 837 women with and without vaccination (2.7 % vs. 3.2 %, respectively), while that of women with influenza B virus infection was significantly lower among women with than without vaccination (0.8 % vs. 1.9 %, respectively; p= 0.0455). Overall, the 2013-2014 vaccination program against influenza reduced the risk of influenza infection by 35 % ([54 -35]/54) among pregnant Japanese women.
Among the 87 women with influenza, 72 (83 %) reported having taken antiviral agents for the treatment of influenza. Antiviral agents administered for these 72 women were oral tablets in 34 (47 %) women and inhalation drugs for the remaining 38 (53 %) women. Two (2.3 %) women required hospitalization for treatment of the influenza; both were multiparous, one with vaccination contracted both influenza A and B viruses, and the other without vaccination contracted influenza A virus.
Discussion
To our knowledge, this is the first study focusing on the behavior of pregnant Japanese women with regard to seasonal influenza.
It may be important to determine the attitudes of pregnant women toward vaccination and antiviral drugs. A survey conducted in the 2006-2007 influenza season in the USA indicated that almost one-third of healthcare workers did not believe that vaccines are a safe and effective way to decrease infections, although the Advisory Committee on Immunization Practices (ACIP) began recommending routine influenza vaccination for healthy pregnant women during the influenza season in 2004 [14] . A meeting designed to integrate scientific evidence and expert opinion [13] in 2008 in the USA concluded that pregnant women should be considered a highpriority group for the receipt of vaccine and that increased seasonal influenza vaccine coverage may improve vaccine uptake in a pandemic [13] . Indeed, during the pandemic (H1N1) 2009, 7.8 % of 102 obstetric patients who required hospitalization for pandemic (H1N1) 2009 died in California [15] . In Australia and New Zealand, pregnant women accounted for 9.1 % of 722 patients who required treatment at an intensive care unit (ICU) [7] and 11 % of 64 pregnant women who required ICU treatment died [8] . Pregnant women accounted for 5 %, 7.5 %, and 8.3 % of hospitalized cases Fig. 1 Prevalence rate of influenza infection according to maternal age among primiparous and multiparous women. *p<0.05 vs. primiparous women. The figures at the top of the bars indicate actual numbers of women with influenza/designated population. The prevalence rate of influenza was consistently higher for multiparous (black bars) than primiparous (white bars) women in all age categories, irrespective of vaccination status. Overall, the infection rate was significantly higher in multiparous than in primiparous women for both vaccinated (5. in Canada, the UK, and Brazil, respectively [16] , although pregnant women account for approximately 1.0 % of the total population. Approximately half of pregnant Japanese women were vaccinated against seasonal influenza. As this figure was similar to those during and after the pandemic (H1N1) 2009 in the USA [17, 18] , it may have been brought about by the pandemic (H1N1) 2009. Before the pandemic (H1N1) 2009, the estimated influenza vaccination coverage among pregnant women in the USA was consistently low (approximately 15 %) [18] [19] [20] , although there is no significant increase in adverse reactions in mothers or neonates related to the vaccine and side effects are similar to those in the general population [19, 20] . Women offered influenza vaccination by a healthcare provider are more likely to be vaccinated and are more likely to have positive attitudes about vaccine effectiveness and safety [18] . The Healthy People 2020 initiative of the U.S. Department of Health and Human Services has set a goal of 80 % vaccine coverage among pregnant women in the USA [21] . As maternal influenza immunization is a highly cost-effective intervention to reduce disease rates and severity corresponding to both seasonal influenza epidemics and occasional pandemics [22] , continued efforts are needed in order to encourage pregnant women to receive influenza vaccination.
Eighty-three percent of infected Japanese women reported having taken antiviral drugs. An early treatment of pregnant women with antiviral medications is associated with fewer ICU admissions and fewer maternal deaths [23] . No harmful effects of neuraminidase inhibitors, including oseltamivir, zanamivir, and laninamivir, on fetuses exposed in utero have been reported [24, 25] , and they are believed to have contributed to the lack of maternal mortality during the pandemic (H1N1) 2009 in Japan [10] [11] [12] .
Multiparous women had an approximately two-fold higher risk of influenza infection compared to primiparous women in this study. To our knowledge, this phenomenon has not been reported to date. The reason for this phenomenon is not yet clear. However, these observations may be explained by the greater number of cohabitants for multiparous than primiparous women, which may be associated with a higher risk of infection.
In conclusion, although it was difficult to verify that respondents answered questions correctly due to the nature of this questionnaire study, our results suggested that influenza vaccine coverage was approximately 50 % among pregnant women in Japan and approximately 1 in 20 pregnant women contracted influenza in the 2013-2014 influenza season. These observations indicated that the higher vaccination level achieved during the pandemic (H1N1) 2009 was sustained. However, the vaccination coverage was insufficient in younger pregnant women, and multiparous women had an approximately two-fold higher risk of infection compared to primiparous women. Continued efforts are needed in order to encourage pregnant women, especially those less than 25 years old and multiparous women, to receive the vaccination to further reduce the number of pregnant women with influenza in Japan.
